Oral Cancer Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Carcinomas, Lymphomas, others), by Treatment (Targeted Therapy, Chemotherapy, Immunotherapy), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), by region, and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationOral Cancer Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Carcinomas, Lymphomas, others), by Treatment (Targeted Therapy, Chemotherapy, Immunotherapy), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), by region, and Competition
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 2.01 billion |
| CAGR (2023-2028) | 5.20% |
| Fastest Growing Segment | Squamous Cell Carcinoma |
| Largest Market | North America |
Market Overview
Global Oral Cancer Treatment Market was valued at USD 2.01 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.20% through 2028.
Ongoing research and development efforts have led to advancements in oral cancer treatment options, including surgery, radiation therapy, chemotherapy, targeted therapies, and immunotherapy. These innovations have improved the prognosis for patients.
Key Market Drivers
Technological Advancements
The development of minimally invasive surgical techniques, such as robotic-assisted surgery, has allowed for more precise tumor removal while minimizing damage to surrounding tissues. Intensity-Modulated Radiation Therapy (IMRT) delivers precise radiation doses to the tumor while sparing healthy tissue. This reduces side effects and improves treatment outcomes. Targeted therapies focus on specific molecular pathways involved in cancer growth. They are designed to be more effective against cancer cells while sparing healthy cells. Immune Checkpoint Inhibitors block certain proteins on the surface of cancer cells, enabling the immune system to recognize and attack the cancer. Immunotherapy has shown promise in some oral cancer cases. A combination of surgery, radiation therapy, and chemotherapy is often used to provide a comprehensive approach to treating oral cancer. Combining therapies can improve treatment outcomes. Genetic and molecular profiling of tumors allows for the identification of specific biomarkers. This information can guide treatment decisions, helping to select the most effective therapy for an individual patient.
Adaptive Radiotherapy technique adjusts the radiation dose based on changes in tumor size and location, ensuring that the tumor receives the necessary treatment while minimizing damage to surrounding healthy tissue. These imaging techniques provide precise tumor localization and help in treatment planning and monitoring. Dental rehabilitation is an integral part of oral cancer treatment. Prosthodontists and oral surgeons work to restore oral function and aesthetics after cancer treatment, which may involve dental implants, dentures, and other dental prostheses. Improved pain management techniques, including nerve blocks, have enhanced the comfort and quality of life for patients undergoing treatment. Telemedicine has become increasingly important, allowing for remote patient monitoring and consultations, especially relevant during the COVID-19 pandemic. Participation in clinical trials provides access to experimental therapies, offering hope for new and potentially more effective treatment options. This factor will help in the development of the
Increasing Early Detection and Screening Programs
Early detection through screening programs allows for the timely diagnosis of oral cancer. When cancer is identified at an early stage, treatment is often more effective, less invasive, and associated with better outcomes. Patients who are diagnosed at later stages of the disease may require more aggressive treatment, which can be more costly and less successful. Early detection of oral cancer is associated with a more favorable prognosis. Patients diagnosed in the early stages have a higher chance of successful treatment and long-term survival. This knowledge encourages individuals to seek screening, as they understand that early detection can be lifesaving. When oral cancer is detected at an advanced stage, it often requires more aggressive and invasive treatment, such as extensive surgery or higher doses of radiation and chemotherapy. Early detection may lead to less aggressive treatment, reducing the physical and emotional burden on patients. Early detection can lead to less extensive surgical procedures, which can help preserve oral function, speech, and aesthetics. This results in an improved quality of life for patients undergoing treatment.
Early detection and treatment of oral cancer are often less costly for both patients and healthcare systems. The financial burden of advanced cancer treatment, which can involve lengthy hospital stays and complex surgeries, is significantly reduced. The existence of screening programs and public awareness campaigns can encourage individuals to undergo regular screenings. As more people participate in screening programs, the number of early-stage diagnoses increases, leading to a higher demand for treatment. Early detection programs may include education on risk factors and prevention. When individuals are informed about the risk factors for oral cancer, they may take preventive measures, such as quitting smoking and reducing alcohol consumption, which can contribute to reducing the overall demand for treatment.
Survivors of oral cancer who were diagnosed early through screening programs often become advocates for early detection and screening. Their stories and advocacy efforts can raise awareness and drive more individuals to seek screenings. The emphasis on early detection has spurred research into better diagnostic tools and techniques. This has led to advancements in the accuracy and accessibility of screening programs, further encouraging participation. By promoting early detection and screening, public health initiatives and healthcare providers contribute to the overall well-being of communities. Reducing the burden of advanced oral cancer cases on healthcare systems benefits society. This factor will pace up the demand of the
Rising Aging Population
Oral cancer, like many other types of cancer, is more commonly diagnosed in older individuals. The risk of developing oral cancer increases with age, which means that as the population ages, the number of cases also rises. Older individuals may have had more cumulative exposure to risk factors associated with oral cancer, such as tobacco and alcohol use. This prolonged exposure increases the likelihood of cancer development. The aging process can lead to a weakening of the immune system. A compromised immune system may be less effective at detecting and preventing the growth of cancer cells, making older individuals more susceptible to oral cancer.
Oral cancer may progress slowly and without noticeable symptoms in its early stages. Older individuals may be less likely to seek medical attention for minor oral health issues, which can result in delayed diagnosis and the need for more extensive treatment. Older adults often have other health conditions, such as diabetes or cardiovascular diseases, which may impact their overall health and the management of cancer treatment. Managing these comorbidities alongside oral cancer can be complex. When oral cancer is diagnosed in older individuals, it is more likely to be in advanced stages. This can necessitate more aggressive treatment approaches, such as extensive surgery or higher doses of radiation and chemotherapy. The increasing life expectancy of the aging population means that more individuals are living longer, increasing the likelihood of developing age-related health conditions, including oral cancer.
Older adults may experience age-related oral health problems, such as tooth loss or the use of dentures. These issues can increase the risk of oral cancer and may also influence the demand for oral cancer treatment. The aging population's access to healthcare services, including cancer screenings and treatment, is a critical factor. Older adults often rely on healthcare systems to manage their health, which drives the demand for oral cancer treatment. Efforts to raise awareness about the importance of regular dental check-ups and oral cancer screenings for the aging population can encourage early detection and timely treatment, which is vital for improving outcomes. This factor will accelerate the demand of the Global Oral Cancer Treatment Market
Key Market Challenges
Side Effects and Quality of Life
Oral cancer treatment modalities, including surgery, radiation therapy, and chemotherapy, can lead to a range of side effects, such as pain, nausea, vomiting, mucositis, fatigue, and hair loss. Managing these side effects is essential to minimize patient discomfort. Oral cancer and its treatment can affect a patient's ability to eat, swallow, and maintain proper nutrition. Weight loss and malnutrition are common concerns, which can impact overall health and quality of life. Treatment can have adverse effects on dental and oral health, potentially leading to tooth decay, gum disease, and difficulty in maintaining oral hygiene. This not only affects comfort but also quality of life. Patients may experience psychological distress, anxiety, depression, and altered body image because of their diagnosis and treatment. Maintaining psychological well-being is vital for a good quality of life. Surgery and radiation therapy can affect the structures involved in speech and communication. Some patients may require speech therapy or assistive devices to maintain effective communication. Swallowing difficulties, known as dysphagia, can arise due to treatment-related changes in the oral and throat areas. Dysphagia affects a patient's ability to eat, drink, and enjoy food, impacting their quality of life. Patients often require dental rehabilitation and prosthetic support following treatment. The restoration of oral function and aesthetics is essential for an improved quality of life.
Drug Resistance
Drug resistance in oral cancer can be either inherent (present from the beginning) or acquired (developed during treatment). Inherent resistance may limit the effectiveness of certain therapies from the outset, while acquired resistance can occur as cancer cells adapt to treatment over time. Drug resistance can render certain treatments, such as chemotherapy or targeted therapy, less effective. When cancer cells become resistant to a specific drug, the treatment may no longer control the disease, leading to disease progression. Oral cancer is not a single disease but rather a group of related diseases with different molecular profiles. Tumor heterogeneity can make it challenging to target all cancer cells effectively, as some cells may be resistant to a specific therapy. Resistance can arise through various mechanisms, including changes in drug transport, alterations in drug targets, activation of alternative signaling pathways, and the development of protective cellular mechanisms. These mechanisms can be complex and difficult to overcome. Drug resistance can limit the number of effective treatment options found at to patients, especially in cases where several lines of therapy have been exhausted. This can limit treatment choices and result in fewer viable options for patients with recurrent or metastatic disease. Some oral cancers may develop resistance to chemotherapy agents, making it challenging to manage the disease, particularly in advanced stages.
Key Market Trends
Adoption of Robotic Surgery
Robotic systems provide unparalleled precision and accuracy during surgery. This is particularly important in oral cancer treatment, where tumors are often located in complex and delicate areas of the mouth and throat. Robotic-assisted surgery allows for minimally invasive approaches to oral cancer treatment. Smaller incisions, reduced tissue damage, and faster recovery times contribute to a better patient experience. The robotic system typically includes high-definition cameras that provide clear, magnified views of the surgical site. This aids surgeons in identifying and removing cancerous tissue while preserving healthy structures. Robotic surgical instruments offer a greater range of motion and dexterity, allowing surgeons to perform precise movements that would be challenging with traditional surgical techniques. Minimally invasive robotic surgery is associated with reduced blood loss, lowering the risk of complications and the need for transfusions. Patients undergoing robotic-assisted surgery for oral cancer treatment often experience shorter hospital stays and quicker recoveries. This minimizes the disruption to their daily lives.
Segmental Insights
Type Insights
In 2022, the Global Oral Cancer Treatment Market largest share was held by Squamous Cell Carcinoma segment and is predicted to continue expanding over the coming years.
Treatment Insights
In 2022, the Global Oral Cancer Treatment Market largest share was held by Immunotherapy segment and is predicted to continue expanding over the coming years.
Distribution Channel Insights
Hospitals pharmacies
Regional Insights
The North America region dominates the Global Oral Cancer Treatment Market in 2022. North America, particularly the United States and Canada, boasts advanced and well-developed healthcare infrastructure. This includes state-of-the-art medical facilities, a skilled healthcare workforce, and access to the latest medical technologies and treatments. The North American region has experienced relatively high incidence rates of oral cancer. This can be attributed to factors such as the prevalence of tobacco and alcohol use, as well as the increased risk associated with certain strains of the human papillomavirus (HPV). High incidence rates drive the demand for oral cancer treatment. North America has been at the forefront of efforts to promote early detection and screening for oral cancer. Regular screenings and early diagnosis are crucial for successful treatment. Public health initiatives and dental professionals play a role in these efforts. The region is a hub for pharmaceutical and biotechnology research and development. Many innovative treatment options and therapies for oral cancer are developed and tested in North America, leading to a broader range of treatment choices. While access to healthcare is a complex issue in North America, compared to many other parts of the world, there is relatively better access to healthcare services. Health insurance coverage and government healthcare programs contribute to this access.
Recent Developments
- In November 2022, ZimVieInc., a prominent player in the global life sciences arena with a strongpresence in the dental and spine sectors, has introduced the TSX Implant in theUnited States. This cutting-edge addition to the company's portfolio ofsurgical, restorative, and digital dentistry solutions is designed forimmediate extraction and loading procedures, providing predictability inplacement, and ensuring primary stability in both soft and dense boneconditions. The TSX Implant incorporates over two decades of real-world clinicaldata to promote peri-implant health, maintain crestal bone, achieve long-termosseointegration, and ensure prosthetic stability. Integrated seamlessly withZimVie's end-to-end digital workflows, the TSX Implant offers versatility forsurgical and restorative applications, reinforcing ZimVie's commitment tostreamlining procedures and enhancing practice protocols. This next-generationimplant is fully compatible with ZimVie's Encode Emergence 3-in-1 HealingAbutment, Impression Coping, and Scanbody System, making it a comprehensivesolution for dental professionals. The TSX Implant has been designed tofacilitate immediate implants, ensuring greater efficiency and predictabilityfor surgeons while being surgically compatible with established protocols,existing tools, and ZimVie's digital dentistry platform.
- In September 2023, Viome Life Sciences, a prominent company dedicated topreventive health technology, has introduced Oral Health Pro with Cancer Detect,a revolutionary test that is poised to transform the dental industry's approachto oral care. This innovative test offers dental professionals an unprecedentedlevel of actionable insights into their patients' health. By leveraging Viome'sproprietary RNA sequencing technology and artificial intelligence (AI), OralHealth Pro with Cancer Detect measures the gene expression of both the oralmicrobiome and human cells in a patient's saliva. This enables the earlydetection of biomarkers associated with oral and throat cancer, leading topotentially life-saving interventions. The significance of this test isunderscored by the FDA's designation of the underlying Cancer Detect technologyas a Breakthrough Device, ensuring an accelerated review process. Oral HealthPro is not only reshaping how dental professionals and individuals view oralhealth but also emphasizing the profound connection between oral well-being andoverall bodily health. The test can identify a wide range of biomarkers relatedto conditions such as gum health, cavities, halitosis, pathobiont activity,fungal activity, and genotoxic activity, many of which have implications forsystemic health.
Key Market Players
- Novartis AG
- Hospira, Inc.
- Teva Pharmaceutical Industries Ltd
- Pfizer Inc.
- Lilly USA, LLC
- Merck & Co., Inc.
- Fresenius Kabi AG
- Accord BioPharma, Inc.
- Bristol-Myers Squibb Company
- Spectrum Pharmaceuticals, Inc.
| By Type | By Treatment | By Distribution Channel | By Region |
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy